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The purpose of this retrospective study was 
therefore to evaluate the imaging features at 
cross-sectional imaging in a series of patients 
with solitary necrotic nodule of the liver, and to 
describe the natural evolution at follow-up for 
2–6 years after histologic diagnosis. Two of 
these patients were included in an earlier re-
port that focused on the imaging features [16] 
but not on the natural history of the nodules.
Materials and Methods
Patients
The imaging examinations of nine patients with 
pathologically proven solitary necrotic nodule of 
the liver were included in this study. Proof of 
diagnosis was based on findings at core-biopsy 
performed with an 18-gauge needle (n = 6) or at 
liver resection (n = 3). Cases were collected from 
four university hospitals over a 6-year period and 
were identified by reviewing pathology databases.
In our patients, solitary necrotic nodules were 
incidentally detected on cross-sectional imaging 
performed for various reasons, such as staging in 
patients with extrahepatic primary malignancies 
(n = 3), abdominal pain (n = 3), and suspected 
gallbladder (n = 2) or urinary (n = 1) stones. 
Institutional review board approval and patient 
consent were not required for this retrospective 
study because patient privacy was maintained and 
patient care was not impacted.
Imaging Protocols and Methods
Sonography was performed in six patients with 
two scanners (Astro MP, Esa Ote-Ansaldo or HDI 
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S
olitary necrotic nodule of the 
liver is a rare benign lesion re-
ported in the pathology and radi-
ology literature [1–21] and might 
result from previous trauma, parasite infec-
tion, or hemangioma [1–6]. At pathology, it 
is characterized by a necrotic central core 
surrounded by a dense hyalinized fibrotic 
capsule. Previous authors have shown that 
solitary necrotic nodule of the liver has 
sometimes been misinterpreted as malignant 
[5–8], leading to inappropriate treatment. To 
that end, awareness and recognition of this 
entity have important implications for patient 
care to avoid errors in management. The ex-
isting knowledge of the imaging features of 
solitary necrotic nodule of the liver is gleaned 
mostly from articles describing one or two 
patients [1–20], and the only case series in-
vestigates the imaging features of solitary 
necrotic nodules of the liver with histopa-
thology [4, 7] or sonography only [21]. To 
our knowledge, no case series describing the 
imaging features of solitary necrotic nodules 
with cross-sectional imaging has been re-
ported except an article that was recently 
published in the non-English-language liter-
ature [22]. Moreover, because the numbers 
of patients with solitary necrotic nodule of 
the liver are small, no information exists on 
the natural history. With the nine patients 
with solitary necrotic nodule of the liver re-
viewed here, we will expand on the informa-
tion gained from prior studies.
Keywords: liver metastases, liver neoplasm, solitary 
necrotic nodules
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OBJECTIVE. The purpose of our study was to retrospectively evaluate the sonographic, 
CT, and MRI findings (number, diameter, lobar location, depth from the hepatic capsule, and 
appearance of lesions) in a series of nine patients with pathologically proven solitary necrotic 
nodules of the liver and the natural evolution at follow-up in four of the nine patients.
CONCLUSION. Solitary necrotic nodules are usually small, solitary lesions, mainly 
located under the liver capsule of the right lobe. They are hypoechoic on sonography, hypoat-
tenuating on CT, have low signal intensity on both T1- and T2-weighted MRI with lack of 
enhancement after IV contrast administration, and at follow-up have a tendency to show cal-
cification and involution toward reduction in size.
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5000, ATL), with 2- to 5-MHz multifrequency 
cur vilinear transducers and frequencies selected 
to optimize imaging of the liver. Color or power 
Doppler sonography was not performed.
Helical multiphasic CT was performed in eight 
patients using Somatom Plus Volume Zoom 4 
(Siemens Medical Solutions) and Brilliance-40 
(Philips Healthcare) units with 3- to 7-mm contig-
uous sections. After unenhanced acquisitions of 
the liver, patients underwent helical multiphase 
CT that included both hepatic arterial phase and 
portal venous phase imaging (25–30 seconds and 
70 seconds, respectively), after IV infusion of 1.5 
mL/kg of body weight of nonionic contrast 
material (iopromide, Ultravist 370, Bayer Schering 
Pharma or iohexol, Omnipaque 300, GE Health-
care). Contrast material was injected at a rate of 
3–5 mL/s with a mechanical power injector 
(Envision CT, MEDRAD).
MRI was performed in five patients with 
various 1.5-T MR units (Gyroscan ACS NT, 
Infinion, or Intera; Philips Healthcare or 
Magnetom Vision, Siemens Medical Solutions) 
with a body or phased-array receive coil. A breath-
hold T1-weighted gradient-recalled echo pulse 
sequence (called FFE on the Philips systems and 
called FLASH on the Siemens systems) was 
performed. The acquisition parameters on the 
scanners from Siemens Medical Solutions were 
TR/TE, 177/4; flip angle, 80°; field of view, 38 
cm; matrix, 256 × 256; number of sections, 20; 
TABLE 1: Synopsis of Demographics and Imaging Findings in Nine Patients with Solitary Necrotic Nodules of Liver
Patient
Nodule Size 
(mm)
Proof of 
Diagnosis Segment (Site) Calcification
Sonographic 
Echogenicitya
CT Attenuation
MRI Signal 
Intensity
Changes at 
Follow-UpNo.
Age 
(y) Sex Unenhancedb CE T1c T2c CE
1 75 M 10 Resection VII (subcapsular) Yes Hyper Hyper No — — No —
2 51 F 10 Resection VII (≈ 1 cm from 
capsule)
Yes Hyper — No — — No —
3 61 M 10 Resection VI (subcapsular) No Hypo Hypo No — — No —
4 30 F 15(I), 10 (FU) Biopsy VI (subcapsular) No (I), yes (FU) Hypo (I), hyper 
(FU)
Hypo (I), hyper 
(FU)
No Hypo Hypo No Calcification 
and size 
reduction
5 40 M 30 (I), 22 (FU) Biopsy VI (subcapsular) No (I), yes (FU) Hypo (I), hyper 
(FU)
Iso (I), hyper 
(FU)
No Hypo Hypo No Calcification 
and size 
reduction
6 37 F 22 (I), 12 (FU) Biopsy VII–VIII (≈ 1 cm 
from capsule)
No (I), yes (FU) Hypo (I), hyper 
(FU)
Hypo (I), hyper 
(FU)
No Iso Hypo No Calcification 
and size 
reduction
7 38 F 38 Biopsy VII (subcapsular) No — Hypo No Hypo Iso No —
8 69 F 10 (I), 7 (FU) Biopsy VIII (> 1 cm from 
capsule)
No (I), no (FU) — Hypo No Hypo Iso No Size 
reduction
9 66 F 40, 18, 10 Biopsy VI (subcapsular) No — Hypo No — — No —
Note—Dash (—) indicates not applicable, CE = contrast-enhanced, I = initial, FU = follow-up.
aHyper = hyperechoic, hypo = hypoechoic.
bHyperattenuating, hypo = hypoattenuating, iso = isoattenuating.
cHypo = hypointense, iso = isointense.
section thickness, 8 mm; and one signal acquired. 
The acquisition parameters on the scanners from 
Philips were TR range/TE range, 146–216/1.5–2.0; 
flip angle, 80°; field of view, 36–40 cm; matrix, 
256 × 192; number of sections, 24; section thick-
ness, 6 mm; and one signal acquired. A respiratory-
triggered T2-weighted fast spin-echo fat-saturated 
pulse sequence was also performed. Siemens 
acquisi tion parameters were as follows: 4000/ 88; 
echo-train length, 33; flip angle, 80°; field of view, 
38 cm; matrix, 256 × 256; number of sections, 20; 
section thickness, 8 mm; and one signal acquir ed. 
Philips acquisition parameters were as fol lows: 
810–970/80–210; echo-train length, 61; field of 
view, 36–40 cm; matrix, 256 × 192; number of 
sections, 48; section thickness, 4 mm; and one 
signal acquired.
The following contrast agents were used. 
Ferumoxides particles (Endorem, Guerbet) were 
injected in one patient. Non-liver-specific gado-
linium chelates ([gadopentetate dimeglumine] 
Magn evist, Bayer Schering Pharma and [gado dia-
mide] Omniscan, GE Health care) were injected in 
five patients, one of whom also had admini stration 
of mangafodipir trisodium (Tesla scan, GE 
Healthcare) during the same exami nation and 
gadoxate (Primovist, Bayer Schering Pharma) at 
follow-up. After manual IV bolus admini stration 
of 0.2 mL/kg of body weight of nonspec ific 
gadolinium chelates, T1-weighted dyna mic 
gradient-recalled echo sequences were performed 
again during the hepatic arterial and portal venous 
phases, at 20 seconds and 60 seconds. A delayed 
acquisition at 4 minutes (range, 3–5 minutes) was 
added. T1-weighted gradient-recalled echo images 
were obtained 20 minutes after the start of 
mangafodipir trisodium infusion or gadoxate 
bolus administration. After IV infusion over 30 
minutes of 6 mL of ferum oxides diluted in 100 
mL of saline solution, a T2-weighted fat-saturated 
turbo spin-echo sequence was performed.
Image Analysis
Imaging studies were evaluated on film by two 
abdominal radiologists (with experience ranging 
from 4 to 20 years) in consensus in each con-
tributing institution and then reevaluated by a 
study coordinator (with 20 years of experience). 
Readers were not blinded to the pathology results. 
When the reviewers and the coordinator expressed 
discordant opinions, they reached a consensus 
through a joint review of the recorded images. Six 
patients underwent sonography; eight patients, 
CT; and five patients, MRI. Four patients under-
went serial examinations.
The following imaging criteria were analyzed: 
number of lesions; lesion diameter; lesion location 
according to the hepatic segment numbering 
system of Couinaud [23]; measurements of the 
depth of the lesion, obtained by measuring the 
greatest distance from the hepatic capsule (a lesion 
was arbitrarily classified as deep or subcapsular 
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when located > 10 or ≤ 10 mm from the hepatic 
surface, respectively); sonographic pattern, classi-
fied as hypoechoic, isoechoic, or hyperechoic to 
the adjacent liver parenchyma; attenuation at 
unenhanced and contrast-enhanced CT, classified 
as hypoattenuating, isoattenuating, or hyperatten-
uating to the adjacent liver parenchyma; signal 
intensity characteristics of the lesions at un-
enhanced and contrast-enhanced T1-weighted 
MRI with regard to the surrounding liver par-
enchyma; and presence and pattern of calci-
fications, defined as discrete, strongly hyper-
attenuating foci on unenhanced CT images. In 
those four patients who underwent serial exami-
nations, we evaluated the evolution of the imag-
ing appearance of the nodules. The nontumorous 
liver was evaluated for the presence of liver 
steatosis or cirrhosis. The grade of liver steatosis 
was defined as absent, mild (0–10%), moderate 
(>10–30%), or severe (>30%).
Pathology
All cases were reviewed retrospectively by one 
pathologist with expertise in hepatic pathology. 
Microscopic examination was performed on 
paraffin-embedded representative sections of the 
lesions, which were routinely processed and 
stained with H and E, and cytologic aspects of 
hepatocytes were noted. Special stains, such as 
elastic van Gieson, reticulin, Grocott-Gomori, 
Ziehl-Neelsen, and periodic acid–Schiff were also 
D
Fig. 1—30-year-old woman with subcapsular solitary necrotic nodule in right lobe of liver (patient 4).
A and B, Nodule (arrow) in segment VI is hypoechoic on sonogram (A) and hypoattenuating on unenhanced CT scan (B).
C and D, At 2-year follow-up, nodule (arrow) is isoechoic and difficult to distinguish from surrounding parenchyma on sonogram (C). Unenhanced CT scan (D) shows 
involution into calcification (arrow).
E and F, At 5-year follow-up, nodule appears slightly hyperechoic and not well identifiable on sonogram (E); acoustic shadowing from calcification is seen (arrow). On CT 
scan (F), nodule (arrow) appears more calcified and smaller in comparison with D.
FE
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performed in selected cases. The morphologic 
diagnosis was based on the presence of a central 
homogeneous eosinophilic necrotic area sur-
rounded by a thin boundary of connective tissue 
[6, 7, 15, 16].
Results
The main findings are summarized in Ta-
ble 1. There was no history of trauma, para-
site infection, or hemangioma in any of the 
patients. Eight patients had a single nodule, 
whereas one patient had a cluster of three 
nodules. Lesions had a mean diameter of 16 
mm (range, 10–40 mm). Lesions were found 
in the right lobe in all cases. Nodules were 
located at a distance of ≤ 10 mm from the 
liver capsule in all but one case.
Sonography
At sonography, noncalcified lesions were 
hypoechoic, whereas calcified lesions were 
hyperechoic (Fig. 1) in comparison with the 
surrounding liver.
CT
At unenhanced CT, lesions were hypoat-
tenuating to the surrounding liver, except 
for calcified lesions that were hyperattenu-
ating to the surrounding liver (Figs. 1–3) 
and for a single lesion that was nearly isoat-
tenuating because there was steatosis of the 
surrounding liver (Fig. 2). No enhancement 
was observed after IV contrast injection in 
any case.
MRI
At MRI, nodules were hypointense on 
both T1- and T2-weighted images except for 
a single case that was nearly isointense on 
T1-weighted images (Fig. 3). None of the 
nodules showed enhancement after gado-
linium injection (Fig. 3). In the patient who 
had images acquired after ferumoxides injec-
tion, loss of signal intensity was observed in 
the liver parenchyma but not in the solitary 
necrotic nodule. No signal change of the 
solitary necrotic nodule was observed in the 
patient who had images acquired after man-
ganese injection. In one patient who under-
went mangafodipir- and gadoxate-enhanced 
MRI, no enhancement of the lesion in the 
liver-specific phase was observed.
Follow-Up and Calcified Nodules
Imaging follow-up was available in four 
cases and ranged from 2 to 6 years. Nodules 
became smaller (n = 4) and calcified (n = 3) 
(Table 1). Two solitary necrotic nodules 
without follow-up imaging were also calci-
fied. Therefore, a total of five solitary ne-
crotic nodules were calcified. Calcifications 
involved the entire lesion in all cases and 
appeared either as homogeneously dense 
masses (Fig. 1) or with an outer rim of in-
creased attenuation and a central core of 
less-intense hyperattenuation (Figs. 2 and 3).
Pathology
With regard to the presence and degree of 
liver steatosis, eight patients had normal 
findings, whereas one patient was considered 
to have moderate steatosis.
Despite intense retrospective review, no 
cause could be established for any of the le-
sions. All solitary necrotic nodules were 
composed of a central eosinophilic necrotic 
area surrounded by a collagenous rim with a 
variable number of elastic fibers and a scant 
number of mononuclear inflammatory cells. 
The necrotic core showed the histologic fea-
tures of the coagulative necrosis: dehydra-
tion and intense cytoplasmic eosinophilia of 
the dead cells (Fig. 4), and it varied as a 
consequence of the presence or absence of 
calcifications, nuclear debris, and ghost or 
inflammatory cells.
A massive calcification of the necrotic 
area was found in two patients (Fig. 4). 
Scarce nuclear debris and rare mononuclear 
inflammatory cells were present in the cen-
tral area in another patient. The necrotic core 
showed some nuclear debris and a large num-
ber of mononuclear inflammatory cells in 
another patient. In no cases were vessels 
A
Fig. 2—40-year-old man with subcapsular solitary 
necrotic nodule in right lobe of liver (patient 5).
A, Unenhanced CT scan shows nearly isoattenuating 
lesion (arrow) in segment VI due to moderate fatty 
infiltration of surrounding liver.
B, Contrast-enhanced CT scan shows 
hypoattenuating lesion (arrow).
C, Unenhanced CT scan at 4-year follow-up shows 
calcified nodule (arrow).
C
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shown, and the hepatic tissue surrounding 
the lesions was normal. Special stains, such 
as Grocott-Gomori, Ziehl-Neelsen, and peri-
odic acid-Schiff, excluded bacterial, fungal, 
and parasitic infections.
Discussion
The imaging and histologic findings in the 
nine patients reported herein reaffirm those 
of previous studies and put some others into 
question. In our series, solitary necrotic nod-
ules were located in a subcapsular area of 
the right lobe of the liver in all but one case. 
These characteristics are in accordance 
with the existing literature. Among 60 cases 
reported in the literature, 73% were right-
sided and 62% were subcapsular [1–6, 8–10, 
12– 21]. In this study, we found a single le-
sion in eight of nine patients and a cluster of 
three lesions in one patient. Occurrence of 
more than one nodule in the same patient 
has been reported in only three studies [3, 
10, 14]. In our series, the mean diameter of 
solitary necrotic nodules was 16 mm, which 
is in accordance with the mean diameter of 
17.6 mm reported by previous authors [1–6, 
8–10, 12–21].
Imaging findings of solitary necrotic nod-
ules in the literature are scant and have most-
ly involved single cases. Solitary necrotic 
nodules imaged in our study were typically 
hypointense on both T1-weighted and T2-
weighted imaging, which is not surprising in 
consideration of the dehydrated, coagulative 
necrosis observed at histopathology. We 
were interested in the observation that our 
pathologists defined the necrosis of solitary 
necrotic nodules as “coagulative” [24, 25], a 
finding that has been typically described in 
the literature as a consequence of previous 
treatment with ablative techniques [26] and 
only occasionally observed in untreated le-
sions [27, 28].
Lack of enhancement after IV contrast in-
jection reflects the avascular nature of soli-
tary necrotic nodules found at histology in 
this study. We believe that the imaging find-
ings reported in this study proved to be non-
specific for characterization of solitary ne-
crotic nodules. Numerous reports on solitary 
necrotic nodules misdiagnosed those as hy-
povascular metastatic lesions [5–8]. Even 
the use of ferumoxides, mangafodipir, and 
gadoxate in two of our cases did not allow a 
specific diagnosis because solitary necrotic 
nodules share the lack of uptake of liver-spe-
cific agents with liver metastases.
D
Fig. 3—37-year-old woman with solitary necrotic nodule in right lobe of liver (patient 6).
A–C, Unenhanced (A) and contrast-enhanced (B) CT scans show subcapsular hypoattenuating lesion (arrow). Nodule is calcified (arrow) on 2-year follow-up CT scan (C).
D–F, MRI performed at same time as C shows lesion (arrow) as hypointense and nearly isointense to surrounding liver parenchyma on transverse T2-weighted fat-
suppressed turbo spin-echo (D) and T1-weighted gradient-echo (E) images, respectively. T1-weighted gadolinium-enhanced gradient-echo MR image (F) shows no 
contrast enhancement within lesion (arrow).
FE
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In our experience, the key findings that 
might increase the ability of radiologists to 
suspect a diagnosis of solitary necrotic nod-
ules are the complete lack of enhancement, 
both in the center and in the periphery, after 
contrast agent administration (although most 
metastases do not show hypervascularity, 
they are all fed by the hepatic artery and will 
indeed show some peripheral rim enhance-
ment after contrast injection) [29] and hypoin-
tensity on T2-weighted images (metastases 
will show hyperintensity on T2-weighted 
images in most cases) [30].
The differential diagnosis between soli-
tary necrotic nodules and liver metastases 
has important implications for patient care. 
Whereas the first warrants conservative 
management, the second are usually treated 
with resection or chemotherapy.
According to previously published reports, 
solitary necrotic nodules are not a specific 
pathologic entity but a consequence of dif-
ferent conditions such as trauma, hemangio-
ma, or parasite infestation [4, 7]. Despite in-
tense retrospective review of histopathology 
specimens, the cause remained unknown in 
our patients. We speculate that diminished 
portal flow in the peripheral zone of the liver 
might have played a role in the pathogenesis 
of solitary necrotic nodules [31].
Previous authors have reported high signal 
intensity on T2-weighted images in two pa-
tients [14, 15] and arterial enhancement with 
cross-sectional imaging [5, 14, 18] and an-
giography [13, 20]. All of our cases showed 
low signal intensity on T2-weighted images 
and lack of enhancement. We postulate that 
these differences can be explained by differ-
ent time points of observation in the evolution 
of solitary necrotic nodules. Early in their de-
velopment, lesions show active inflammatory 
changes and angiogenesis that might be re-
sponsible for the high signal intensity on T2-
weighted images [15] and the enhancement 
shown after contrast injection [13]. At a later 
stage, necrosis and devascularization can 
explain the different imaging appearances 
observed in our study [16].
We believe that we have shown the natural 
history of solitary necrotic nodules. In those 
patients whom we followed up for extended 
periods, we were able to show progressive 
diminution in size in all cases and metamor-
phosis into a calcified lesion in three cases. 
Two other patients in this study had calcified 
lesions. We speculate that these two cases 
likely would have appeared as noncalcified, 
nonenhancing lesions if imaged earlier. We 
believe that a prospective study evaluating 
the morphologic evolution of a larger number 
of solitary necrotic nodules at the initial 
stage (when calcifications have not devel-
oped yet) would be beneficial in confirming 
this hypothesis.
In two review articles [32, 33] listing the 
causes of calcified liver lesions, no mention 
was made of solitary necrotic nodules as a 
potential cause of hepatic calcifications. 
However, our results show that solitary ne-
crotic nodules should be included as one of 
the potential causes of liver calcifications.
It is important to recognize the limita-
tions of our study. The numbers reported are 
limited because they are relatively small, re-
flecting the rareness of this condition and 
Fig. 4—Histopathologic features of various noncalcified and calcified solitary necrotic nodules of liver.
A and B, Photomicrographs from 30-year-old woman with subcapsular solitary necrotic nodule in right lobe of liver (patient 4). Lesion consists of core of eosinophilic 
coagulative necrosis (asterisk) clearly separated from surrounding liver tissue by rim of collagenous tissue (arrows). (H and E, ×100)
C, Photomicrograph from 40-year-old man with subcapsular solitary necrotic nodule in right lobe of liver (patient 5) shows necrotic area containing some inflammatory 
mononuclear cells (arrows). (H and E, ×200)
D, Photomicrograph from 37-year-old woman with solitary necrotic nodule in right lobe of liver (patient 6) shows large number of mononuclear inflammatory cells (arrows) 
and some nuclear debris (circles) in necrotic area. (H and E, ×200)
E, Photomicrograph from 75-year-old man with subcapsular solitary necrotic nodule (patient 1). Central necrotic core due to coagulative necrosis shows several calcium 
depositions (arrows). Different tone of this photomicrograph in comparison with A–C is due to different time of tissue fixation. (H and E, ×200)
D E
A CB
1128 AJR:191, October 2008
Colagrande et al.
necessitating a retrospective study design. 
Another limitation is that cases collected 
from multiple institutions over many years 
lack uniformity with regard to imaging and 
pathologic analysis. A further limitation is 
that not every patient and every lesion under-
went imaging with all three cross-sectional 
imaging techniques.
In conclusion, solitary necrotic nodules 
are usually small, solitary lesions mostly 
found under the liver capsule of the right 
lobe and showing hypoattenuation on CT 
and hypointensity on both T1- and T2-
weighted MRI. Lack of enhancement after 
IV contrast injection should alert the radiolo-
gist to a possible diagnosis of solitary necrot-
ic nodule and lead to pathologic confirma-
tion. The evolution toward calcification is a 
further clue to this diagnosis.
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